BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Back to Balance Sheet
|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Last 5 Year Total Liabilities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Liabilities | ₹162 Cr | ₹192 Cr | ₹84 Cr | ₹113 Cr | ₹115 Cr |
What is the latest Total Liabilities ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹162 Cr |
Mar2022 | ₹192 Cr |
Mar2021 | ₹84 Cr |
Mar2020 | ₹113 Cr |
Mar2019 | ₹115 Cr |
How is Total Liabilities of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹162 Cr | -15.50 | |
Mar2022 | ₹192 Cr | 128.51 | |
Mar2021 | ₹84 Cr | -25.65 | |
Mar2020 | ₹113 Cr | -1.84 | |
Mar2019 | ₹115 Cr | - |
Compare Total Liabilities of peers of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | ₹106.1 Cr | -6.4% | 0.2% | -21.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,461.0 Cr | 1.4% | -4.1% | 32.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,983.0 Cr | -4.2% | -5.1% | 59.6% | Stock Analytics | |
CIPLA | ₹112,735.0 Cr | -2.2% | -7.3% | 0.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,913.9 Cr | -7.1% | -13.8% | 8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,815.0 Cr | -6.4% | -5.2% | 31.2% | Stock Analytics |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | -6.4% |
0.2% |
-21.9% |
SENSEX | -2.2% |
-4% |
5.5% |
You may also like the below Video Courses